The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
Super Bowl LX is set to showcase a surge in GLP-1 weight-loss drug ads from telehealth giants like Ro featuring Serena Williams and Novo Nordisk's Ozempic and Wegovy. With record $8-10M ad slots, health trends dominate alongside AI and celebrity-packed spots with George Clooney and Kendall Jenner. This 'GLP-1 Super Bowl' highlights booming demand for metabolic health solutions.
Super Bowl LX ads are packed with celebrities from Kendall Jenner to George Clooney, cutting-edge AI demos, and a surge in health spots promoting GLP-1 weight-loss drugs like Ozempic and Wegovy. As viewership hits record highs, advertisers are betting big on telehealth and pharma amid booming demand. This preview reveals the trends shaping America's biggest ad showdown.
Shares in Novo Nordisk, maker of Ozempic and Wegovy, plunged 18% after a sales warning flagged up to 13% decline in the US market due to falling GLP-1 drug prices. Despite 2025 sales growth of 6% to 309 billion kronor, the stock wipeout erased $32 billion in value. CEO Mike Doustdar highlights the upcoming Wegovy pill as a key future driver.
New topline data from the REIMAGINE 2 trial reveal CagriSema outperforms semaglutide in HbA1c reduction and weight loss for adults with type 2 diabetes inadequately controlled on metformin. Patients on CagriSema 2.4mg/2.4mg saw a 1.91% point HbA1c drop and 14.2% body weight loss at 68 weeks. This combination of cagrilintide and semaglutide sets a new benchmark in T2D therapy.
Jason Krynicki, once bullied for obesity, now battles anorexia while on Zepbound, fearing weight regain if he stops. GLP-1 drugs curb appetite effectively but complicate lives for those with disordered eating, often without proper screening. Experts highlight risks and call for caution in a weight-stigma culture.
New Zealand's Pharmac advisory panel has recommended funding Wegovy for chronic weight management in those with high BMI and related conditions. Paediatric endocrinologist Professor Wayne Cutfield argues strongly for including obese teens to prevent lifelong health crises. This guide breaks down the science, evidence, and implications.
When 7-year-old Jessa injected her mom's Ozempic thinking it was stomach medicine, she faced severe vomiting, dehydration, and kidney risks. This incident underscores the dangers of GLP-1 medications like semaglutide and tirzepatide in children. Discover prevention tips and what to do in an emergency.
GLP-1 medications like Ozempic and Wegovy are transforming weight management, but older adults face heightened risks like muscle loss and fractures. This guide breaks down the science-backed concerns, monitoring strategies, and when to avoid them. Stay informed to make safer health choices.
When Bollywood star Tamanna Bhatia appeared slimmer, social media buzzed with Ozempic accusations, sparking debates on beauty standards and rapid weight loss. Beyond the rumors, Ozempic (semaglutide) is a powerful GLP-1 drug transforming weight management. This guide dives into the science, risks, and healthier paths forward.
